Upadacitinib 15 mg plus a 26-week GC taper outperformed placebo in combination with a 52-week GC taper for the treatment of ...

Lipocine Inc. , a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced the publication and discussion of a ...

This article explores the feasibility of simulated placements, incorporating digital technologies alongside classroom-based ...

Dramatic study results point to the potential for a steroid-sparing option for patients with the underrecognized multiorgan ...

Solengepras is a potentially first-in-class, oral, non-dopaminergic investigational therapy in development for Parkinson’s ...

Intellia presented data from its Phase I study of NTLA-2001 at the 2024 American Heart Association scientific meeting in ...

While research is limited, some studies show that consuming certain spices, such as chili pepper, turmeric, and cinnamon, may ...

The SARAH trial was limited to high-risk patients, which the lead investigator said prevented unnecessary exposure to adverse ...

Faced with a diagnosis of an incurable, life-threatening condition, for some the answer to their prayers can come in the form ...

A V2X transponder installed on road work vehicles and signs ensures detection without needing cellular coverage or manual ...

TORONTO and PHILADELPHIA, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd (NASDAQ: MDCX TSXV: MDCX) (the “Company”) is pleased to announce the appointment of Faisal Mehmud, MD as Chief Medical ...

Black Friday is not until 29 November, but deals are already live. Here are the best US picks that I've found already: from ...